June 4, 2020 / 6:26 AM / a month ago

BRIEF-GlaxoSmithKline Pharmaceuticals Says Profitability Of Q1FY21 May Be Impacted Due To COVID-19

June 4 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd :

* CURRENTLY OPERATING AT ABOUT 70% OF NORMATIVE MANUFACTURING LEVELS

* SEEN SLOWDOWN IN SALES ACROSS THERAPEUTIC AREAS DURING Q1

* PERFORMANCE & PROFITABILITY OF Q1FY21 MAY BE IMPACTED Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below